The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

London’s Guy’s Hospital has become one of the first to prescribe weight-loss jabs. The central London hospital, part of the ...

WHAT IT MEANS FOR PATIENTSThe potential for more aggressive price cuts would enable wider access to GLP-1 drugs - the same ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

The US plans to slash the price it pays for Novo Nordisk's Ozempic and Wegovy, the latest drugs to be targeted under legislation that's expected save the government more than $200 billion over a ...

Charlotte, 50, a UK events manager, was struggling with her weight and menopause symptoms before turning to the groundbreaking device ...

Investing.com -- Shares of Novo Nordisk (NYSE: NVO) fell 3.6% on Friday after the U.S. Department of Health and Human ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

European stocks advanced for four consecutive weeks as miners rose on a report Rio Tinto Group and Glencore Plc have ...

Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

Diana Collette went from size 16 to size 10 on weight loss drug Mounjaro. She coped well with the side effects too – nausea ...